These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2371096

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [N-acetyl-beta-D-glucosaminidase (NAG) in the urine. An additional parameter for diagnosing the site of urinary tract infection].
    Ring E, Erwa W, Zobel G.
    Monatsschr Kinderheilkd; 1989 May; 137(5):280-3. PubMed ID: 2739666
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Evaluation of N-acetyl-beta glucosaminidase in upper and lower urinary tract infections in childhood. Clinical study of 168 children].
    Belli A, Scalercio F, Martino F, Guido F, Aprigliano D, Lorusso G, Mannarino O, Ruberto U.
    Minerva Pediatr; 1996 Nov; 48(11):503-7. PubMed ID: 9064498
    [Abstract] [Full Text] [Related]

  • 5. [The excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with urinary tract diseases].
    Zandvliet EE, Giesberts MA, van Gelderen HH.
    Tijdschr Kindergeneeskd; 1983 Aug; 51(4):135-8. PubMed ID: 6670088
    [Abstract] [Full Text] [Related]

  • 6. Renal tubular markers as screening tools for severe vesicoureteral reflux.
    García-Nieto V, García-Rodríguez VE, Luis-Yanes MI, Monge M, Arango-Sancho P, Garin EH.
    Eur J Pediatr; 2019 Apr; 178(4):525-531. PubMed ID: 30706159
    [Abstract] [Full Text] [Related]

  • 7. Urinary levels of renal tubular enzyme N-acetyl-beta-D-glucosaminidase in relation to grade of vesicoureteral reflux.
    Carr MC, Peters CA, Retik AB, Mandell J.
    J Urol; 1991 Aug; 146(2 ( Pt 2)):654-6. PubMed ID: 1861320
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changing concepts concerning the management of vesicoureteral reflux.
    Herndon CD, DeCambre M, McKenna PH.
    J Urol; 2001 Oct; 166(4):1439-43. PubMed ID: 11547107
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urinary N-acetyl-beta-glucosaminidase as a screening technique for vesicoureteral reflux.
    Williams MA, Jones D, Noe HN.
    Urology; 1994 Apr; 43(4):528-30. PubMed ID: 8154076
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [NAG (N-acetyl-beta-D-glucosaminidase)--a sensitive marker for disorders of kidney function].
    Skrezek C, Bertermann H, Schulz FP, König B.
    Urologe A; 1990 Jan; 29(1):27-31. PubMed ID: 2316078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.